Response to Letter to the Editor: "Cardiovascular Effects of Pioglitazone or Sulfonylureas According to Pretreatment Risk: Moving Toward Personalized Care".

Response to Letter to the Editor: "Cardiovascular Effects of Pioglitazone or Sulfonylureas According to Pretreatment Risk: Moving Toward Personalized Care". J Clin Endocrinol Metab. 2020 Mar 01;105(3): Authors: Vaccaro O, Nicolucci A, Lucisano G, Masulli M, Riccardi G PMID: 32036387 [PubMed - in process]

https://www.ncbi.nlm.nih.gov/pubmed/32036387?dopt=Abstract

Source: The Journal of Clinical Endocrinology and Metabolism - February 10, 2020 Category: Endocrinology Authors: Vaccaro O, Nicolucci A, Lucisano G, Masulli M, Riccardi G Tags: J Clin Endocrinol Metab Source Type: research

More News: Actos | Cardiology | Cardiovascular | Endocrinology | Heart